GENE ONLINE|News &
AI and 3D Printing Integration Poised to Accelerate Generic Drug Development, According to DrugPatentWatch
Technological advancements are reshaping generic drug development, potentially leading to faster and more efficient processes, according to a recent report by DrugPatentWatch. The report highlights the integration of technologies like artificial intelligence and 3D printing into the generic drug development lifecycle. These innovations are poised to reduce the time and cost typically associated with bringing generic treatments to market. The DrugPatentWatch article details how these technological improvements are contributing to increased accessibility and affordability of essential medications. AI-powered discovery tools are accelerating the identification of potential drug candidates, while 3D printing offers the potential for more efficient and customized drug formulation. The integration of these technologies promises to streamline the development process, ultimately impacting the availability of life-saving treatments globally.
Newsflash | Powered by GeneOnline AI
Date: April 14, 2025
Author
LATEST
David vs. Goliath: Taiwan’s PGI Wins $23M Settlement in Sequencing Patent Dispute with U.S. PacBio
2026-03-13
Gut Microbiome Composition Predicts Long-term Cardiometabolic Health Outcomes in Diverse Urban Populations
2026-03-12
NVIDIA Ahead of GTC 2026: Markets Focus on Data Center Strength, PC Expansion, and the Next Technical Breakout
2026-03-12
Global and APAC Biopharma Watch: Capital Raising, Clinical Expansion, and Industry Moves in Focus
2026-03-12
EVENT
2026-04-09
4th Cell & Gene Therapy Innovation & Access Congress: Asia (Media Partnership)
Seoul, South Korea
2026-04-17
AACR Annual Meeting 2026 (Cancer Research & Early-Stage Breakthroughs)
San Diego, California
